ABSTRACT
2 patients underwent saphenous vein-coronary artery bypass grafting before successful renal transplantation. Both patients were able to undergo appropriate therapy for various complications, which further emphasizes the resilience that these patients can have after adequate coronary revascularization.
Subject(s)
Coronary Artery Bypass , Kidney Transplantation , Saphenous Vein/transplantation , Adult , Humans , Male , Time Factors , Transplantation, Autologous , Transplantation, HomologousABSTRACT
An elderly patient with traumatic aortic valvular insufficiency was treated surgically with valve replacement, the preferred method of treatment, since prognosis is poor without timely surgical therapy. Further emphasis should be given to early diagnosis of this lesion.
Subject(s)
Aortic Valve/injuries , Thoracic Injuries/complications , Wounds, Nonpenetrating/complications , Aged , Aortic Valve/surgery , Aortic Valve Insufficiency/diagnosis , Aortic Valve Insufficiency/etiology , Female , Humans , RuptureABSTRACT
Urinary diversion may be used in patients without a bladder or with irreversible, lower urinary tract abnormalities who might not otherwise be suitable candidates for renal transplantation. Three cases have been described to illustrate three different methods of supravesical urinary diversion that have been employed in association with renal transplantation.
Subject(s)
Kidney Transplantation , Urinary Diversion/methods , Adolescent , Colon, Sigmoid/surgery , Cystitis/etiology , Follow-Up Studies , Humans , Ileostomy , Male , Nephrectomy , Postoperative Complications , Splenectomy , Suppuration , Transplantation, Homologous , Ureter/surgery , Urinary Bladder/surgery , Urinary Bladder Neck Obstruction/surgery , Urinary Tract/abnormalitiesABSTRACT
During a prospective study, 13 patients received renal transplants from cadaveric donors whose hearts beat up to the time of their death. These donors were pretreated with cyclophosphamide-methylprednisolone (group A) or methylprednisolone-procarbazine hydrochloride (group B). After a minimum follow-up of 12 months, all grafts in group A but only one graft in group B survived. On the basis of this small experience, the combination of cyclophosphamide and methylprednisolone seems to be superior to that of methylprednisolone and procarbazine hydrochloride in reducing allograft immunogenicity. In order to achieve longer survival of the graft in the recipient, pretreatment with procarbazine hydrochloride has been discontinued. Pretreatment of the potential cadaveric allograft donor with cyclophosphamide and methylprednisolone is being continued at our institution.
